Update on Animal Models of Sjogren Syndrome

doi:10.3969/j.issn.1005-4979.2014.06.015

Abstract

Key words: Sjogren syndrome, animal models, mouse, autoimmunity

CLC Number:

R739.87

CAO Ning-ning, ZHENG Ling-yan. Update on Animal Models of Sjogren Syndrome[J]. 《Journal of Oral and Maxillofacial Surgery》, 2014, 24(6): 462-.

曹宁宁，郑凌艳. 舍格伦综合征动物模型的研究进展[J]. 《口腔颌面外科杂志》, 2014, 24(6): 462-.

/ / Recommend / Download Citations

URL: https://journal06.magtech.org.cn/Jweb_joms/EN/10.3969/j.issn.1005-4979.2014.06.015

https://journal06.magtech.org.cn/Jweb_joms/EN/Y2014/V24/I6/462

[1] Delaleu N, Nguyen CQ, Peck AB, et al. Sjogren's syndrome: studying the disease in mice [J]. Arthritis Res Ther, 2011, 13(3):217.

[2] Delaleu N, Jonsson MV, Appel S, et al. New concepts in the pathogenesis of Sjogren's syndrome[J]. Rheum Dis Clin North Am, 2008, 34(4):833-845.

[3] Fox RI. Sjogren's syndrome[J]. Lancet, 2005, 366(9482):321-331.

[4] Lavoie TN, Lee BH, Nguyen CQ. Current concepts: mouse models of Sjogren's syndrome[J]. J Biomed Biotechnol,2011, 2011:549107.

[5] Ciháková D, Talor MV, Barin JG, et al. Sex differences in a murine model of Sjogren's syndrome[J]. Ann N Y Acad Sci, 2009, 1173:378-383.

[6] Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European consensus group[J]. Ann Rheum Dis, 2002, 61（6）:554-558.

[7] Chiorini JA, Cihakova D, Ouellette CE, et al. Sjogren syndrome: advances in the pathogenesis from animal models[J]. J Autoimmun, 2009, 33(3-4):190-196.

[8] Soyfoo MS, Steinfeld S, Delporte C. Usefulness of mouse models to study the pathogenesis of Sjogren's syndrome [J]. Oral Dis, 2007, 13(4):366-375.

[9] Hu Y, Nakagawa Y, Purushotham KR, et al. Functional changes in salivary glands of autoimmune disease-prone NOD mice [J]. Am J Physiol, 1992, 263(4 Pt 1):E607-E614.

[10] Humphreys-Beher MG. Animal models for autoimmune disease-associated xerostomia and xerophthalmia[J]. Adv Dent Res, 1996, 10(1):73-75.

[11] Lee BH, Gauna AE, Pauley KM, et al. Animal models in autoimmune diseases: lessons learned from mouse models for Sjogren's syndrome[J]. Clin Rev Allergy Immunol,2012, 42(1):35-44.

[12] Brayer J, Lowry J, Cha S, et al. Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjogren's syndrome-like autoimmune exocrinopathy[J]. J Rheumatol, 2000, 27(8):1896-1904.

[13] Kong L, Robinson CP, Peck AB, et al. Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice[J]. Clin Expl Rheumatol, 1998, 16(6):675-681.

[14] Brayer J, Lowry J, Cha S, et al. Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjogren's syndrome-like autoimmune exocrinopathy[J]. J Rheumatol, 2000, 27(8):1896-1904.

[15] Brayer JB, Cha S, Nagashima H, et al. IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD. IL-4-gene knockout mouse model of Sjogren's syndrome [J]. Scand J Immunol, 2001, 54(1-2):133-140.

[16] Cha S, Brayer J, Gao J, et al. A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse[J]. Scand J Immunol, 2004, 60(6):552-565.

[17] Xiao W, Wu Y, Zhang J, et al. Selecting highly sensitive non-obese diabetic mice for improving the study of Sjogren's syndrome[J]. Graefes Arch Clin Exp Ophthalmol, 2009, 247(1):59-66.

[18] Kessler HS. A laboratory model for Sjogren's syndrome [J]. Am J Pathol, 1968, 52(3):671-685.

[19] Kessler HS, Cubberly M, Manski W. Eye changes in autoimmune NZB and NZB x NZW mice. Comparison with Sjogren's syndrom [J]. Arch Ophthalmol, 1971, 85(2):211-219.

[20] 李春蕾,郝杨,华红. 舍格伦综合征动物模型研究进展 [J]. 中国实用口腔科杂志, 2009, 2(4):244-247.

[21] Ono S, Shao D, Yamada S, et al. A novel function of B lympho-cytes from normal mice to suppress autoimmunity in（NZB x NZW）F1 mice [J]. Immunology, 2000, 100(1):99-109.

[22] Staszak C, Harbeck RJ. Mononuclear-cell pulmonaryvasculitis in NZB/W mice. I. Histopathologic evaluation of spontaneously occurring pulmonary infiltrates [J]. Am J Pathol, 1985, 120(1):99-105.

[23] Kamao T, Miyazaki T, Soga Y, et al. Genetic dissociation of dacryoadenitis and sialadenitis in a Sjogren's syndrome mouse model with common and different susceptibility gene loci [J]. Invest Ophthalmol Vis Sci, 2009, 50(7):3257-3265.

[24] Van Blokland SCA, Versnel MA. Pathogenesis of Sjogren's syndrome: characteristics of different mouse models for autoimmune exocrinopathy [J]. Clin Immunol, 2002, 103(2):111-124.

[25] Hayashi Y, Kojima A, Hata M, et al. A new Mutation involving the sublingual gland in NFS/N mice. Partially arrested mucous cell differentiation[J]. Am J Pathol, 1988, 132(2):187-191.

[26] Hayashi Y, Haneji N, Hamano H, et al. Effector mechanism of experimental autoimmune sialadenitis in themouse model for primary Sjogren's syndrome[J]. Cell Immunol, 1996, 171(2):217-225.

[27] Haneji N, Nakamura T, Takio K, et al. Identification ofα-fodrin as a candidate autoantigen in primary Sjogren's syndrome [J]. Science, 1997, 276(5312):604-607.

[28] Saegusa J, Kubota H. Sialadenitis in IQI/Jic mice: A new animal model of Sjogren's syndrome[J]. J Vet Med Sci,1997, 59(10):897-903.

[29] Jonsson MV, Delaleu N, Jonsson R. Animal models of Sjogren's syndrome [J]. Clin Rev Allergy Immunol, 2007, 32(3):215-224.

[30] Takada K,Takiguchi M,Konno A, et al. Spontaneous development of multiple glandular and extraglandular lesions in aged IQI/Jic mice: a model for primary Sjogren's syndrome[J]. Rheumatology(Oxford), 2004, 43(7):858-862.

[31] Takada K, Takiguchi M, Konno A, et al. Autoimmunity against a tissue kallikrein in IQI/Jic mice: a model for Sjogren's syndrome [J]. J Biol Chem, 2005, 280(5):3982-3988.

[32] 李钧. 舍格伦综合征动物模型的研究 [J]. 北京口腔医学, 2001,9(3):151-153.

[33] Tsubata R, Tsubata T, Hiai HR, et al. Autoimmune disease of exocrine organs in immunodeficient alymphoplasia mice: a spontaneous model for Sjogren's syndrome[J]. Eur J Immunol, 1996, 26(11):2742-2748.

[34] Garberg H, Jonsson R, Brokstad KA. The serologicl pattern of autoantibodies to the Ro52 Ro60, and La48 autoantigens in primary in Sjogren's Syndrome patients and healthy controls [J]. Scand J Rheumatol, 2005, 34(1):49-55.

[35] Scofield RH, Asfa S, Obeso D, et al. Immunization with short peptides from the 60-kDa Ro antigen recapitulates the serological and pathological findings as well as the salivary gland dysfunction of Sjogren's syndrome [J]. J Immunol, 2005, 175(12):8409-8414.

[36] Nishimori I, Bratanova T, Toshkov I, et al. Induction of experimental autoimmune sialoadenitis by immunization of PL/J mice with carbonic anhydrase II[J]. J Immunology, 1995, 154(9):4865-4873.

[37] Dawson LJ, Fox PC, Smith PM. Sjogren syndrome--the non-apoptotic model of glandular hypofunction[J]. Rheumatology (Oxford), 2006, 45(7):792-798.

[38] Fleck M, Kern ER, Zhou T, et al. Murine cytomegalovirus induces a Sjogren's syndrome-like disease in C57B1/6-lpr/lpr mice[J]. Arthritis Rheum, 1998, 41(12):2175-2184.

Please choose a citation manager

Content to export